The Dow Jones Industrial Average finished with a gain of 317.24 points, or 0.7%, at 44,873.28, led by gains for Amgen, Goldman Sachs, Sherwin-Williams and Nvidia. The S&P 500 ended 23.60 points higher ...

BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...

Amgen investors have been focused on prospects for MariTide, which activates the appetite- and blood sugar-reducing hormone ...

(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...

Amgen stock skidded late Tuesday after the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...

Asian shares are trading mostly higher after a Wall Street rally that followed profit reports from major companies ...

The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

Shares of the Vernon Hills, Illinois-based company rose 2.3% in premarket trading. The company is also benefiting from the ...

After a four-day guessing game and much financial turbulence, the United States and China appear to have resumed a ...